Safety and toxicity of nanomaterials for ocular drug delivery applications

References

• Abrego G, Alvarado H, Souto EB, Guevara B, Bellowa LH, Parra A, et al. 2015. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration. Eur J Pharm Biopharm J Biopharm 95:261–70.
   PubMed Web of Science ®Google Scholar
• Aksungur P, Demirbilek M, Denkbas EB, Vandervoort J, Ludwig A, Unlu N. 2011. Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake and kinetic studies. J Control Release 151:286–94.
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobao P, Lobo JMS. 2014. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today 19:400–12.
   PubMed Web of Science ®Google Scholar
• Anayol MA, Toklu Y, Kamberoglu EA, Raza S, Arifoglu HB, Simavli H, et al. 2014. Short-term effects of intravitreal triamcinolone acetonide injection on ocular blood flow evaluated with color Doppler ultrasonography. Int J Ophthalmol 7:811–15.
   PubMed Web of Science ®Google Scholar
• Andrei F, Peptu CA, Popa M, Desbrieres J, Peptu C, Gardikiotis F, et al. 2015. Formulation and evaluation of cefuroxim loaded submicron particles for ophthalmic delivery. Int J Pharm 493:16–29.
   PubMed Web of Science ®Google Scholar
• Angelopoulou A, Voulgari E, Diamanti EK, Gournis D, Avgoustakis K. 2015. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel. Eur J Pharm Biopharm 93:18–26.
   PubMed Web of Science ®Google Scholar
• Aoshima H, Saitoh Y, Ito S, Yamana S, Miwa N. 2009. Safety evaluation of highly purified fullerenes (HPFs): based on screening of eye and skin damage. J Toxicol Sci 34:555–62.
   PubMed Web of Science ®Google Scholar
• Azar DT. 2006. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing. Trans Am Ophthalmol Soc 104:264–302.
   PubMedGoogle Scholar
• Badawi AA, El-Laithy HM, El Qidra EK, Mofty HE, EI Dally M. 2008. Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res 31:1040–9.
   PubMed Web of Science ®Google Scholar
• Bajwa N, Mehra NK, Jain K, Jain NK. 2015a. Pharmaceutical and biomedical applications of quantum dots. Artif Cells Nanomed Biotechnol. doi: 10.3109/21691401.2015.1052468.
   Web of Science ®Google Scholar
• Bajwa N, Mehra NK, Jain K, Jain NK. 2015b. Targeted anticancer drug delivery through anthracycline antibiotic bearing functionalized quantum dots. Artif Cells Nanomed Biotechnol. doi: 10.3109/21691401.2015.1102740.
   Google Scholar
• Barile FA. 2010. Validating and troubleshooting ocular in vitro toxicology tests. J Pharmacol Toxicol Methods 61:136–45.
   PubMed Web of Science ®Google Scholar
• Bhatta RS, Chandasana H, Chhonker YS, Rathi C, Kumar D, Mitra K, Shukla PK. 2012. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies. Int J Pharm 432:105–12.
   PubMed Web of Science ®Google Scholar
• Bochot A, Fattal E. 2012. Liposomes for intravitreal drug delivery: a state of the art. J Control Release 161:628–34.
   PubMed Web of Science ®Google Scholar
• Boczkowski J, Lanone S. 2012. Respiratory toxicities of nanomaterials – a focus on carbon nanotubes. Adv Drug Deliv Rev 64:1694–9.
   PubMed Web of Science ®Google Scholar
• Bozukova D, Pagnoulle C, Jerome R, Jerome C. 2010. Polymers in modern ophthalmic implants-historical background and recent advances. Mat Sci Eng R 69:63–83.
   Web of Science ®Google Scholar
• Cai D, Gao W, He B, Dai W, Zhang H, Wang X, et al. 2014. Hydrophobic penetrating peptide PFVYLi-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. Biomaterials 35:2283–94.
   PubMed Web of Science ®Google Scholar
• Chen D, Dougherty CA, Zhu K, Hong H. 2015. Theranostic applications of carbon nanomaterials in cancer: focus on imaging and cargo delivery. J Control Release 210:230–45.
   PubMed Web of Science ®Google Scholar
• Chen Y, Hu X, Sun J, Zhou O. 2015. Specific nanotoxicity of graphene oxide during zebrafish embryogenesis. Nanotoxicology. doi: 10.3109/17435390.2015.1005032.
   Web of Science ®Google Scholar
• Chetoni P, Burgalassi S, Monti D, Najarro M, Boldrini E. 2007. Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity. J Drug Deliv Sci Technol 17:43–8.
   Web of Science ®Google Scholar
• Chetoni P, Monti D, Tampucci S, Matteoli B, Ceccherini-Nelli L, Subissi A, Burgalassi S. 2015. Liposomes as a potential ocular delivery system of distamycin A. Int J Pharm 492:120–6.
   PubMed Web of Science ®Google Scholar
• Conley SM, Naash MI. 2010. Nanoparticles for retinal gene therapy. Prog Retin Eye Res 29:376–97.
   PubMed Web of Science ®Google Scholar
• Coursey TG, Henriksson JT, Marcano DC, Shin CS, Isenhart LC, Ahmed F, et al. 2015. Dexamethasone nanowafer as an effective therapy for dry eye disease. J Control Release 213:168–74.
   PubMed Web of Science ®Google Scholar
• Das S, Bellare JR, Banerjee R. 2012. Protein based nanoparticles as platforms for aspirin delivery for ophthalmologic applications. Colloids Surf B Biointerfaces 93:161–8.
   PubMed Web of Science ®Google Scholar
• Daull P, Lallemand F, Garrigue JS. 2013. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. J Pharm Pharmacol 66:531–41.
   Web of Science ®Google Scholar
• De la Fuente M, Seijo B, Alonso MJ. 2008. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci 49:2016–24.
   PubMed Web of Science ®Google Scholar
• Desai PN, Yuan Q, Yang H. 2010. Synthesis and characterization of photocurable polyamidoamine dendrimer hydrogels as a versatile platform for tissue engineering and drug delivery. Biomacromolecules 11:666–73.
   PubMed Web of Science ®Google Scholar
• Devadasu VR, BHardwaj V, Kumar MNV. 2013. Can controversial nanotechnology promise drug delivery? Chem Rev 113:1686–735.
   PubMed Web of Science ®Google Scholar
• Diebold Y, Calonge M. 2010. Applications of nanoparticles in ophthalmology. Prog Retin Eye Res 29:596–609.
   PubMed Web of Science ®Google Scholar
• Dilbaghi N, Kaur H, Ahuja M, Kumar S. 2013. Evaluation of tropicamide-loaded tamarind seed xyloglucan nanoaggregates for ophthalmic delivery. Carbohydr Polym 94:286–91.
   PubMed Web of Science ®Google Scholar
• Dong P, Guan Y, Yang J, He M, Wan C. 2000. Fundus microvascular flow monitoring during retrograde cerebral perfusion: an experimental study. Ann Thorac Surg 70:1478–82.
   PubMed Web of Science ®Google Scholar
• Draize JH, Woodard G, Calvery HO. 1994. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–90.
   Google Scholar
• Du J, Wang S, You H, Zhao X. 2013. Understanding the toxicity of carbon nanotubes in the environment is crucial to the control of nanomaterials in producing and processing and the assessment of health risk for human: a review. Environ Toxicol Pharmacol 36:451–62.
   PubMed Web of Science ®Google Scholar
• Duan Y, Cai X, Du H, Zhai G. 2015. Novel in situ gel systems based on P123/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin. Colloids Surf B Biointerfaces 128:322–30.
   PubMed Web of Science ®Google Scholar
• Ema M, Matsuda A, Kobayashi N, Naya M, Nakanishi J. 2011. Evaluation of dermal and eye irritation and skin sensitization due to carbon nanotubes. Regul Toxicol Pharmacol 61:276–81.
   PubMed Web of Science ®Google Scholar
• Fernandez-Ferreiro A, Barcia MG, Martinez MG, Prado AV, Lema I, Argibay B, et al. 2015. In vitro and in vivo ocular safety and eye surface permanence determination by direct and magnetic resonance imaging of ion-sensitive hydrogels based on gellan gum and kappa-carrageenan. Eur J Pharm Biopharm 94:342–51.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick SD, Mazumder MAJ, Muirhead B, Sheardown H. 2012. Development of injectable, resorbable drug-releasing copolymer scaffolds for minimally invasive sustained ophthalmic therapeutics. Acta Biomater 8:2517–28.
   PubMed Web of Science ®Google Scholar
• Fuller JR, Bevin TH, Molteno AC, Vote BJ, Herbison P. 2002. Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complications. Br J Ophthalmol 86:1352–4.
   PubMed Web of Science ®Google Scholar
• Gallarate M, Chirio D, Bussano R, Peira E, Battaglia L, Baratta F, Trotta M. 2013. Development of O/W nanoemulsions for ophthalmic administration of timolol. Int J Pharm 440:126–34.
   PubMed Web of Science ®Google Scholar
• Gan L, Gan Y, Zhu C, Zhang X, Zhu J. 2009. Novel micro-emulsion in situ electrolyte-triggered gelling systems for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results. Int J Pharm 365:143–9.
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez MJ, Tabary N, Martel B, Cazaux F, Oliva A, Taboada, et al. 2013. Pol-(cyclo) dextrins as ethoxzolamide carriers in ophthalmic solutions and in contact lenses. Carbohydr Polym 98:1343–52.
   PubMed Web of Science ®Google Scholar
• Griffith JF, Nixon GA, Bruce RD, Reer PJ, Bannan EA. 1980. Dose–response studies with chemical irritants in the albino rabbit eye as a basis for selecting optimum testing conditions for predicting hazard to the human eye. Toxicol Appl Pharmacol 55:501–13.
   PubMed Web of Science ®Google Scholar
• Guerra J, Herrero MA, Carrion B, Perez-Martinez FC, Lucio M, Rubio N, et al. 2012. Carbon nanohorns functionalized with polyamidoamine dendrimers as efficient biocarrier materials for gene therapy. Carbon 50:2832–44.
   Web of Science ®Google Scholar
• Habib FS, Fouad EA, Abdel-Rhaman MS, Fathalla D. 2010. Liposomes as an ocular delivery system of fluconazole: in vitro studies. Acta Ophthalmol 88:901–4.
   PubMed Web of Science ®Google Scholar
• Halim Mohamed MA, Mahmoud AA. 2011. Formulation of indomethacin eye drops via complexation with cyclodextrins. Curr Eye Res 36:208–16.
   PubMed Web of Science ®Google Scholar
• Hamalainen KM, Kananen K, Auriola S, Kontturi K, Urtti A. 1997. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci 38:627–34.
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. 2007. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:E1–12.
   PubMed Web of Science ®Google Scholar
• Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Beuschel SL, Butnor KJ, et al. 2010. Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Ann N Y Acad Sci 1203:7–14.
   PubMed Web of Science ®Google Scholar
• Hironaka K, Inokuchi Y, Fujisawa T, Shimazaki H, Akane M, Tozuka Y, et al. 2011. Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage. Eur J Pharm Biopharm 79:119–25.
   PubMed Web of Science ®Google Scholar
• Holden CA, Tyagi P, Thakur A, Kadam R, Jadhav G, Kompella UB, Yang H. 2012. Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs. Nanomedicine 8:776–83.
   PubMed Web of Science ®Google Scholar
• Hsueh PY, Edman MC, Sun G, Shi P, Xu S, Lin Y, et al. 2015. Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal gland. J Control Release 208:2–13.
   PubMed Web of Science ®Google Scholar
• Huang W, Collette W, Twamley M, Aguirre SA, Sacaan A. 2015. Application of electroretinography (ERG) in early drug development for assessing retinal toxicity in rats. Toxicol Appl Pharmacol 289:525–33.
   PubMed Web of Science ®Google Scholar
• http://www.drugs.com/restasis.html. Accessed on 13 December 2015.
   Google Scholar
• Huczko A, Lange H, Calko E, Grubek-Jaworska H, Droszcz P. 2001. Physiological testing of carbon nanotubes: are they asbestos-like? Fullerene Sci Technol 9:251–4.
   Web of Science ®Google Scholar
• Huhtala A, Salminen L, Tahti H, Uusitalo H. 2008. Corneal models for the toxicity testing of drugs and drug releasing materials. In: Ashammakhi N, ed. Topics in Multifunctional Biomaterials and Devices, 1–24. in press, Available at: http://www.oulu.fi/spareparts/ebook_topics_multifunctional/abstracts/huhtala.pdf
   Google Scholar
• Ibrahim HK, El-Leithy IS, Makky AA. 2010. Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy. Mol Pharm 7:576–85.
   PubMed Web of Science ®Google Scholar
• Jain AK, Mehra NK, Lodhi N, Dubey V, Mishra DK, Jain PK, Jain NK. 2007. Carbon nanotubes and their toxicity. Nanotoxicology 1:167–97.
   Web of Science ®Google Scholar
• Jain K, Mehra NK, Jain NK. 2014. Potentials and emerging trends in nanopharmacology. Curr Opin Pharmacol 15:97–106.
   PubMed Web of Science ®Google Scholar
• Jain K, Mehra NK, Jain NK. 2015. Nanotechnology in drug delivery: safety and toxicity issues. Curr Pharm Des 21:4252–61.
   PubMed Web of Science ®Google Scholar
• Jaiswal M, Kumar M, Pathak K. 2015. Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis. Colloids Surf B Biointerfaces 130:23–30.
   PubMed Web of Science ®Google Scholar
• Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. 2010. Silver nano – a trove for retinal therapies. J Control Release 145:76–90.
   PubMed Web of Science ®Google Scholar
• Kapoor Y, Chauhan A. 2008. Ophthalmic delivery of cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels. Int J Pharm 361:222–9.
   PubMed Web of Science ®Google Scholar
• Kapoor Y, Thomas JC, Tan G, John VT, Chauhan A. 2009. Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs. Biomaterials 30:867–78.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Kakkar S. 2014. Nanotherapy for posterior eye diseases. J Control Release 193:100–12.
   PubMed Web of Science ®Google Scholar
• Kayat J, Gajbhiye V, Tekade RK, Jain NK. 2011. Pulmonary toxicity of carbon nanotubes: a systematic report. Nanomedicine 7:40–9.
   PubMed Web of Science ®Google Scholar
• Kim YC, Oh KH, Edelhauser HF, Prausnitz MR. 2015. Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles. Eur J Pharm Biopharm. 95(Pt B):398–406.
   Web of Science ®Google Scholar
• Kirchhof S, Goepferich AM, Brandl FP. 2015. Hydrogels in ophthalmic applications. Eur J Pharm Biopharm. 95(Pt B):227–38.
   Web of Science ®Google Scholar
• Kishore AS, Surekha PS, Murthy PB. 2009. Assessment of the dermal and ocular irritation potential of multi-walled carbon nanotubes by using in vitro and in vivo methods. Toxicol Lett 191:268–74.
   PubMed Web of Science ®Google Scholar
• Kjellstrom U, Andreasson S, Ponjavic V. 2014. Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication. Acta Ophthalmol 92:149–57.
   PubMed Web of Science ®Google Scholar
• Kompella UB, Amrite AC, Ravi RP, Durazo SA. 2013. Nanomedicines for back of the eye drug delivery, gene delivery and imaging. Prog Retin Eye Res 36:172–98.
   PubMed Web of Science ®Google Scholar
• Korenfield MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS. 2009. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg 35:26–34.
   PubMed Web of Science ®Google Scholar
• Koz OG, Ozhuy S, Tezel GG, Karaman N, Unlu N, Yarangumeli A, Kural G. 2007. The effect of paclitaxel on conjunctival wound healing: a pilot study. J Glaucoma 16:610–15.
   PubMed Web of Science ®Google Scholar
• Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG. 2002. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma 11:287–93.
   PubMed Web of Science ®Google Scholar
• Kuo TR, Lee CF, Lin SJ, Dong CY, Chen CC, Tan HY. 2011. Studies of intracorneal distribution and cytotoxicity of quantum dots: risk assessment of eye exposure. Chem Res Toxicol 24:253–61.
   PubMed Web of Science ®Google Scholar
• Lacerda L, Russier J, Pastorin G, Herrero MA, Venturelli E, Dumortier H, et al. 2012. Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials 33:333–43.
   PubMed Web of Science ®Google Scholar
• Lajunen T, Viitala L, Kontturi LS, Laaksonen T, Liang H, Vuorimaa-Laukkanen E, et al. 2015. Light induced cytosolic drug delivery from liposomes with gold nanoparticles. J Control Release 203:85–98.
   PubMed Web of Science ®Google Scholar
• Lallemand F, Duall P, Benita S, Buggage R, Garrigue JS. 2012. Successfully improving ocular drug delivery using the cationic nanoemulsion, Novasorb. J Drug Deliv 2012:604204.
   PubMedGoogle Scholar
• Lee EH, Kim JK, Lim JS, Lim SJ. 2015. Enhancement of indocyanine green stability and cellular uptake by incorporating cationic lipid into indocyanine green-loaded nanoemulsions. Colloids Surf B Biointerfaces 136:305–13.
   PubMed Web of Science ®Google Scholar
• Leonardi A, Bucolo C, Romano GL, Platania CBM, Drago F, Puglisi G, Pignaello R. 2014. Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. Int J Pharm 470:133–40.
   PubMed Web of Science ®Google Scholar
• Lezzi R, Guru BR, Glybina IV, Mishra MK, Kennedy A, Kannan RM. 2012. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials 33:979–88.
   PubMed Web of Science ®Google Scholar
• Li J, Wu L, Wu W, Wang B, Wang Z, Xin H, Xu Q. 2013. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Int J Pharm 455:75–84.
   PubMed Web of Science ®Google Scholar
• Li N, Zhuang C, Wang M, Sun X, Nie S, Pan W. 2009. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 379:131–8.
   PubMed Web of Science ®Google Scholar
• Liang H, Baudouin C, Duall P, Garrigue JS, Brignole-Baudouin F. 2012. Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound healing model and an acute in vivo rabbit model. Mol Vis 18:2195–204.
   PubMed Web of Science ®Google Scholar
• Lin M, Zou R, Shi H, Yu S, Li X, Guo R, et al. 2015. Ocular biocompatibility evaluation of hydroxyl-functionalized graphene. Mater Sci Eng C Mater Biol Appl 50:300–8.
   PubMed Web of Science ®Google Scholar
• Liu K, Wang Y, Li H, Duan Y. 2015. A facile one-pot synthesis of starch functionalized graphene as nano-carrier for pH-sensitive and starch-mediated drug delivery. Colloids Surf B Biointerfaces 128:86–93.
   PubMed Web of Science ®Google Scholar
• Lopes JF, Moster MR, Wilson RP, Altangerel U, Alvim HS, Tong MG, et al. 2006. Subconjunctival sodium hyaluronate 2.3% in trabeculectomy: a prospective randomized clinical trial. Ophthalmology 113:756–60.
   PubMed Web of Science ®Google Scholar
• Lu Y, GuoXing L, Shu Z, Fei S, XiaoJie H, Qian Z, et al. 2013. Cytotoxicity and genotoxicity of multi-walled carbon nanotubes with human ocular cells. Mater Chem 58:2347–53.
   Google Scholar
• Ludwig A. 2005. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 57:1595–639.
   PubMed Web of Science ®Google Scholar
• Manna S, Banerjee RK, Augsburger JJ, Al-Rjoub MF, Donnell A, Correa ZM. 2015. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetic and toxicity in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 253:1297–305.
   PubMed Web of Science ®Google Scholar
• Mao HY, Laurent S, Chen W, Akhavan O, Imani M, Ashkarran AA, Mahmoudi M. 2013. Graphene: promises, facts, opportunities and challenges in nanomedicine. Chem Rev 113:3407–24.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Marzio LD, Rinaldi F, Celia C, Paolino D, Alhaique F, et al. 2014. Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci 205:187–206.
   PubMed Web of Science ®Google Scholar
• Majdi JA, Qian H, Li Y, Langsner RJ, Shea KI, Agrawal A, et al. 2015. The use of time-lapse optical coherence tomography to image the effects of microapplied toxins on the retina. Invest Ophthalmol Vis Sci 56:587–97.
   Web of Science ®Google Scholar
• Mehra NK, Jain K, Jain NK. 2015a. Pharmaceutical and biomedical applications of surface engineered carbon nanotubes. Drug Discov Today 20:750–6.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Jain K, Jain NK. 2015b. Design of multifunctional nanocarriers for delivery of anti-cancer therapy. Curr Pharm Des 21:6157–64.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Jain NK. 2015a. Multifunctional hybrid-carbon nanotubes: new horizon in drug delivery and targeting. J Drug Target. 24:294–308.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Jain NK. 2015b. Cancer targeting propensity of folate conjugated surface engineered multi-walled carbon nanotubes. Colloids Surf B Biointerfaces 132:17–26.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Jain NK. 2015c. One platform comparison of estrone and folic acid anchored surface engineered MWCNTs for doxorubicin delivery. Mol Pharm 12:630–43.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Mishra V, Jain NK. 2014a. A review of ligand tethered surface engineered carbon nanotubes. Biomaterials 35:1267–83.
   PubMed Web of Science ®Google Scholar
• Mehra NK, Palakurthi S. 2015. Interactions between carbon nanotubes and bioactives: a drug delivery perspective. Drug Discov Today. doi: 10.1016/j.drudis.2015.11.011.
   Web of Science ®Google Scholar
• Mehra NK, Verma AK, Mishra PR, Jain NK. 2014b. The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes. Biomaterials 35:4573–88.
   PubMed Web of Science ®Google Scholar
• Mishra V, Jain NK. 2014. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits. Int J Pharm 461:380–90.
   PubMed Web of Science ®Google Scholar
• Miyawaki J, Yudasaka M, Azami T, Kubo Y, Iijima S. 2008. Toxicity of single-walled carbon nanohorns. ACS Nano 2:213–26.
   PubMed Web of Science ®Google Scholar
• Mody N, Tekade RK, Mehra NK, Chopdey P, Jain NK. 2014. Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential. AAPS PharmSciTech 15:388–99.
   PubMed Web of Science ®Google Scholar
• Moysidis SN, Alvarez-Delfin K, Peschansky VJ, Salero E, Weisman AD, Bartakova A, et al. 2015. Magnetic field-guided cell delivery with nanoparticle-loaded human corneal endothelial cells. Nanomedicine 11:499–509.
   PubMed Web of Science ®Google Scholar
• Myles ME, Neumann DM, Hill JM. 2005. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv Drug Deliv Rev 57:2063–79.
   PubMed Web of Science ®Google Scholar
• Nagai N, Ito Y. 2014. Therapeutic effects of gel ointments containing tranilast nanoparticles on paw edema in adjuvant-induced arthritis rats. Biol Pharm Bull 37:96–104.
   PubMed Web of Science ®Google Scholar
• Nagai N, Ito Y, Okamoto N, Shimomura Y. 2014. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. Toxicology 319:53–62.
   PubMed Web of Science ®Google Scholar
• Nair KL, Vidyanand S, James J, Kumar GS. 2012. Pilocarpine-loaded poly (dl-lactic-co-glycolic acid) nanoparticles as potential candidates for controlled drug delivery with enhanced ocular pharmacological response. J Appl Polym Sci 124:2030–6.
   Web of Science ®Google Scholar
• OECD (Organisation for Economic Co-operation and Development). 2002. OECD guideline for the testing of chemicals: acute eye irritation/corrosion (Test No. 405).
   Google Scholar
• Oshima Y, Sakamoto T, Nakamura T, Tahara Y, Goto Y, Ishibashi T, Inomata H. 1999. The comparative benefits of glaucoma filtering surgery with an electric-pulse targeted drug delivery system demonstrated in an animal model. Ophthalmology 106:1140–6.
   PubMed Web of Science ®Google Scholar
• Pathak MK, Chhabra G, Pathak K. 2013. Design and development of a novel pH-triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Dev Ind Pharm 39:780–90.
   PubMed Web of Science ®Google Scholar
• Pattni BS, Chupin VV, Torchilin VP. 2015. New developments in liposomal drug delivery. Chem Rev 115:10938–66.
   PubMed Web of Science ®Google Scholar
• Peng D, Yu K, Zeng S, Li Y, Lin J, Wu Y, Zhou W. 1999. An experimental study on homoharringtonine liposome and glaucoma filtration surgery. Yan Ke Xue Bao 15:51–4.
   PubMedGoogle Scholar
• Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. 2002. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen®. Eur J Pharm Sci 16:53–61.
   PubMed Web of Science ®Google Scholar
• Plange N, Remky A, Arend O. 2003. Colour Doppler imaging and fluorescein filling defects of the optic disc in normal tension glaucoma. Br J Ophthalmol 87:731–6.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Noonan JS. 1998. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 87:1479–88.
   PubMed Web of Science ®Google Scholar
• Prow TW. 2010. Toxicity of nanomaterials to the eye. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2:317–33.
   PubMed Web of Science ®Google Scholar
• Prow TW, Bhutto I, Kim SY, Grebe R, Merges C, McLeod S, et al. 2008. Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine 4:340–9.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Qin G, Yu L. 2013. The triblock copolymers hydrogel through intracameral injection may be a new potential ophthalmic drug delivery with antiscarring drugs after glaucoma filtration surgery. Med Hypotheses 80:23–5.
   PubMed Web of Science ®Google Scholar
• Rai P, Lauande-Pimentel R, Barton K. 2005. Amniotic membrane as an adjunct to donor sclera in the repair of exposed glaucoma drainage devices. Am J Ophthalmol 140:1148–52.
   PubMed Web of Science ®Google Scholar
• Rajala A, Wang Y, Zhu Y, Ranjo-Bishop M, Ma JX, Mao C, Rajala RV. 2014. Nanoparticle-assisted targeted delivery of eye-specific genes to eyes significantly improves the vision of blind mice in vivo. Nano Lett 14:5257–63.
   PubMed Web of Science ®Google Scholar
• Ratto F, Matteini P, Rossi F, Menabuoni L, Tiwari N, Kulkarni SK, Pini R. 2009. Photothermal effects in connective tissues mediated by laser-activated gold nanorods. Nanomedicine 5:143–51.
   PubMed Web of Science ®Google Scholar
• Roggeband R, York M, Pericoi M, Braun W. 2000. Eye irritation responses in rabbit and man after single application of equal volume of undiluted model liquid detergent products. Food Chem Toxicol 38:727–34.
   PubMed Web of Science ®Google Scholar
• Reimondez-Troitino S, Csaba N, Alonso MJ, de la Fuente M. 2015. Nanotherapies for the treatment of ocular diseases. Euro J Pharm Biopharm 95(Pt B):279–93.
   Web of Science ®Google Scholar
• Sasaki H, Karasawa K, Hironaka K, Tahara K, Tozuka Y, Takeuchi H. 2013. Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes. Eur J Pharm Biopharm 83:364–9.
   PubMed Web of Science ®Google Scholar
• Sharma A, Tandon A, Tovey JCK, Gupta R, Robertson JD, Fortune JA, et al. 2011. Polyethylenimine-conjugated gold nanoparticles: gene transfer potential and low toxicity in the cornea. Nanomedicine 7:505–13.
   PubMed Web of Science ®Google Scholar
• Sharma P, Mehra NK, Jain K, Jain NK. 2015. Biomedical applications of carbon nanotubes: a critical review. Curr Drug Deliv 12 (In press).
   Google Scholar
• Sharma R, Ahuja M, Kaur H. 2012. Thiolated pectin nanoparticles: preparation, characterization and ex vivo corneal permeation study. Carbohydr Polym 87:1606–10.
   Web of Science ®Google Scholar
• Sheikholeshlami P, Muirhead B, Baek DSH, Wang H, Zhao X, Sivakumaran D, et al. 2015. Hydrophobically-modified poly(vinyl pyrrolidone) as a physically-associative, shear-responsive ophthalmic hydrogel. Exp Eye Res 137:18–31.
   PubMed Web of Science ®Google Scholar
• Soderstjerna E, Bauer P, Cedervall T, Abdshill H, Johansson F, Johansson UE. 2014. Silver and gold nanoparticles exposure to in vitro cultured retina-studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity. PLoS One 9:e105359.
   PubMed Web of Science ®Google Scholar
• Sosnik A, Neves J, Sarmento B. 2014. Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review. Prog Polym Sci 39:2030–75.
   Web of Science ®Google Scholar
• Souza JG, Dias K, Silva SAM, de Rezende LCD, Rocha EM, Emery FS, Lopez RFV. 2015. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery. J Control Release 200:115–24.
   PubMed Web of Science ®Google Scholar
• Spataro G, Malecaze F, Turrin CO, Soler V, Duhayon C, Elena PP, et al. 2010. Designing dendrimers for ocular drug delivery. Eur J Med Chem 45:326–34.
   PubMed Web of Science ®Google Scholar
• Spitzer MS, Yoeruek E, Kaczmarek RT, Sierra A, Aisenbrey S, Grisanti S, et al. 2008. Sodium hyaluronate gels as a drug release system for corticosteroids: release kinetics and anti-proliferative potential for glaucoma surgery. Acta Ophthalmol 86:842–8.
   PubMed Web of Science ®Google Scholar
• Srivastava V, Gusain D, Sharma YC. 2015. Critical review on the toxicity of some widely used engineered nanoparticles. Ind Eng Chem Res 54:6209–33.
   Web of Science ®Google Scholar
• Taha EI, Ei-Anazi MH, El-Bagory IM, Bayomi MA. 2014. Design of liposomal colloidal systems for ocular delivery of ciprofloxacin. Saudi Pharm J 22:231–9.
   PubMed Web of Science ®Google Scholar
• Tayel SA, El-ANabarawi MA, Tadros MI, Abd-Elsalam WH. 2013. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm 443:293–305.
   PubMed Web of Science ®Google Scholar
• Tommaso CD, Torriglia A, Furrer P, Behar-Cohen F, Gurny R, Moller M. 2011. Ocular biocompatibility of novel cyclosporine A formulations based on methoxypoly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. Int J Pharm 416:515–24.
   PubMed Web of Science ®Google Scholar
• Tripathi RC, Tfipathi BJ. 2005. Tissue plasminogen activator therapy for the eye. Br J Ophthalmol 89:1390–1.
   PubMed Web of Science ®Google Scholar
• Tuomela A, Liu P, Puranen J, Ronkko S, Laaksonen T, Kalesnykas G, et al. 2014. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo. Int J Pharm 467:34–41.
   PubMed Web of Science ®Google Scholar
• Vandamme TF, Brobeck L. 2005. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release 102:23–38.
   PubMed Web of Science ®Google Scholar
• Varshocian R, Jeddi-Tehrani M, Mahmoudi AR, Khoshayand MR, Atyabi F, Sabzevari A, et al. 2013. The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments. Eur J Pharm Sci 50:341–52.
   PubMed Web of Science ®Google Scholar
• van Velthoven ME, Faber DJ, Verbraak FD, van Leeuwen TG, de Smet MD. 2007. Recent developments in optical coherence tomography for imaging the retina. Prog Retin Eye Res 26:57–77.
   PubMed Web of Science ®Google Scholar
• Volkov Y. 2015. Quantum dots in nanomedicine: recent trends, advances and unresolved issues. Biochem Biophys Res Commun. 468:419–27.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhang J, Huang Y, Huang J, Jiang J. 2011. Clinical study on interferon treatment of early scarring in filtering bleb. Eye Sci 26:197–200.
   PubMedGoogle Scholar
• Warsi MH, Anwar M, Garg V, Jain GK, Talegaonkar S, Ahmad FJ, Khar RK. 2014. Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits. Colloids Surf B Biointerfaces 122:423–31.
   PubMed Web of Science ®Google Scholar
• Wilson SL, Ahearne M, Hopkinson A. 2015. An overview of current techniques for ocular toxicity testing. Toxicology 327:32–46.
   PubMed Web of Science ®Google Scholar
• Wong TT, Khaw PT, Aung T, Foster PJ, Htoon HM, Oen FT, et al. 2009. The Singapore 5-fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years. Ophthalmology 116:175–84.
   PubMed Web of Science ®Google Scholar
• Wu YT, Willcox M, Zhu H, Stapleton F. 2015. Contact lens hygiene compliance and lens case contamination: a review. Cont Lens Anterior Eye 38:307–16.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Yasueda S, Isowaki A, Yamamoto M, Kimura M, Inada K, Ohtori A. 2005. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Int J Pharm 301:121–8.
   PubMed Web of Science ®Google Scholar
• Yan L, Wang Y, Xu X, Zeng C, Hou J, Lin M, et al. 2012. Can graphene oxide cause damage to eyesight?. Chem Res Toxicol 25:1265–70.
   PubMed Web of Science ®Google Scholar
• Yan L, Li GX, Zhang S, Sun F, Huang X, Zhang Q, et al. 2013. Cytotoxicity and genotoxicity of multi-walled carbon nanotubes with human ocular cells. Chinese Sci Bull 58:2347–53.
   Google Scholar
• Yang H, Tyagi P, Kadam RS, Holden CA, Kompella UB. 2012. Hybrid dendrimers hydrogel/PLGA nanoparticles platform sustains drug delivery for one week and anti-glaucoma effects for four days following one-time topical administration. ACS Nano 6:7596–606.
   Google Scholar
• Yang L, Wang F, Han H, Yang L, Zhang G, Fan Z. 2015. Functionalized graphene oxide as a drug carrier for loading pirfenidone in treatment of subarachnoid hemorrhage. Colloids Surf B Biointerfaces 129:21–9.
   PubMed Web of Science ®Google Scholar
• Yellepeddi VK, Vangara KK, Palakurthi S. 2013. Poly (amido) amine (PAMAM) dendrimer-cisplatin complexes for chemotherapy of cisplatin-resistant ovarian cancer cells. J Nanopart Res 15:1897.
   Web of Science ®Google Scholar
• Yin H, Gong C, Shi S, Liu X, Wei Y, Qian Z. 2010. Toxicity evaluation of biodegradable and thermosensitive PEG-PCL-PEG hydrogel as a potential in situ sustained ophthalmic drug delivery system. J Biomed Mater Res Part B: Appl Biomater 92:129–37.
   PubMed Web of Science ®Google Scholar
• Yuan X, Marcano DC, Shin CS, Hua X, Isenhart LC, Pflugfelder SC, Acharya G. 2015. Ocular drug delivery nanowafer with enhanced therapeutic efficacy. ACS Nano 9:1749–58.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang S. 2009. Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerances, precorneal retention and anti-cataract effect. Int J Pharm 372:66–75.
   PubMed Web of Science ®Google Scholar